1972
DOI: 10.1038/newbio239083a0
|View full text |Cite
|
Sign up to set email alerts
|

Human Tumours grown in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

1
16
0

Year Published

1973
1973
2006
2006

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(17 citation statements)
references
References 2 publications
1
16
0
Order By: Relevance
“…THE development of xenografting techniques, enabling human tumours to be grown in immune-suppressed mice (as shown for example by Castro, 1972, andCobb, 1973), has made it possible to experiment in the laboratory on tumours of human origin, and to study the effect on them of the cytotoxic agents used in cancer therapy.…”
mentioning
confidence: 99%
“…THE development of xenografting techniques, enabling human tumours to be grown in immune-suppressed mice (as shown for example by Castro, 1972, andCobb, 1973), has made it possible to experiment in the laboratory on tumours of human origin, and to study the effect on them of the cytotoxic agents used in cancer therapy.…”
mentioning
confidence: 99%
“…CARCINOMA arising in the large bowel in man can be transplanted successfully subcutaneously in immune deprived animals (Povlsen and Rygaard, 1971;Castro, 1972;Cobb, 1972). If we wish to use this xenograft model to learn more about a tumour in man, we need to understand to what extent transplantation to a xenogeneic host alters the tumour cell population.…”
mentioning
confidence: 99%
“…Following the demonstration by Rygaard and Povlsen (1969) that human tumours could be grown in congenitally athymic mice and the subsequent use of thymectomised, whole-body irradiated mice suitable for tumour heterotransplantation (Castro, 1972), large numbers of serially transplantable human tumour xenograft lines have been established (Shimosato et al, 1976Giovanella et al, 1978). In spite of extensive data on the establishment, biological characteristics and drug response of these xenografts, their clinical relevance is not yet clear.…”
mentioning
confidence: 99%